Iovance Biotherapeutics Inc (IOVA)
Cost of Revenue
$167.68M
TTM · Period ending: · USD
IOVA Cost of Revenue
Latest reported$167.68Mperiod ending
Latest reported$167.68Mperiod ending
IOVA TTM Cost of Revenue ($0.00 → $167.68M)
TTM cost of revenue
High-resolution chart · PNG
IOVA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 167,681,000 | |
| 172,967,000 | |
| 173,184,000 | |
| 175,616,000 | |
| 176,962,000 | |
| 159,449,000 | |
| 123,995,000 | |
| 82,817,000 | |
| 47,334,000 | |
| 18,016,000 | |
| 10,755,000 | |
| 6,390,000 | |
| 2,050,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 290,000 | |
| 290,000 | |
| 290,000 | |
| 290,000 | |
| 0 | |
| 2,660,000 | |
| 2,660,000 | |
| 2,660,000 | |
| 11,996,000 | |
| 11,785,000 | |
| 13,534,000 | |
| 15,491,000 | |
| 10,810,000 | |
| 8,361,000 | |
| 7,391,260 | |
| 5,434,260 | |
| 7,256,260 | |
| 8,634,260 | |
| 7,855,000 | |
| 7,855,000 | |
| 1,378,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |